Universal Ibogaine Inc. (IBOGF)
USD 0.02
(0.0%)
USD 0.02
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2022 | 1.01 Million CAD | 277.75% |
| 2021 | 267.8 Thousand CAD | 469.38% |
| 2020 | -72.5 Thousand CAD | 64.62% |
| 2019 | -204.92 Thousand CAD | -294.69% |
| 2018 | -51.92 Thousand CAD | 86.61% |
| 2017 | -387.75 Thousand CAD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 Q2 | 2.08 Million CAD | 30.96% |
| 2023 Q1 | 1.59 Million CAD | 57.7% |
| 2023 Q3 | 2.29 Million CAD | 10.02% |
| 2022 FY | 1.01 Million CAD | 277.75% |
| 2022 Q1 | -2.03 Million CAD | -29348.74% |
| 2022 Q4 | 1.01 Million CAD | 1170.98% |
| 2022 Q3 | -94.45 Thousand CAD | 0.0% |
| 2021 Q1 | -36.88 Thousand CAD | 68.86% |
| 2021 FY | 267.8 Thousand CAD | 469.38% |
| 2021 Q4 | 6941.00 CAD | 110.97% |
| 2021 Q3 | -63.26 Thousand CAD | -904.54% |
| 2021 Q2 | 7864.00 CAD | 121.32% |
| 2020 Q2 | -97.66 Thousand CAD | 42.03% |
| 2020 Q1 | -168.47 Thousand CAD | 14.36% |
| 2020 FY | -72.5 Thousand CAD | 64.62% |
| 2020 Q4 | -118.42 Thousand CAD | -63.35% |
| 2020 Q3 | -72.5 Thousand CAD | 25.77% |
| 2019 Q3 | -204.92 Thousand CAD | 13.56% |
| 2019 FY | -204.92 Thousand CAD | -294.69% |
| 2019 Q1 | -252.39 Thousand CAD | -798.76% |
| 2019 Q2 | -237.08 Thousand CAD | 6.07% |
| 2019 Q4 | -196.71 Thousand CAD | 4.01% |
| 2018 Q4 | -28.08 Thousand CAD | 45.91% |
| 2018 Q1 | -245.44 Thousand CAD | 60.94% |
| 2018 FY | -51.92 Thousand CAD | 86.61% |
| 2018 Q3 | -51.92 Thousand CAD | 0.0% |
| 2017 FY | -387.75 Thousand CAD | 0.0% |
| 2017 Q4 | -628.31 Thousand CAD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Bioxytran, Inc. | 1.89 Million USD | 46.726% |
| Eiger BioPharmaceuticals, Inc. | 15.76 Million USD | 93.582% |
| Institute of Biomedical Research Corp. | 401.84 Thousand USD | -151.743% |
| SQZ Biotechnologies Company | -36.23 Million USD | 102.792% |
| Intellipharmaceutics International Inc. | 2.24 Million USD | 54.883% |
| Evofem Biosciences, Inc. | 42.79 Million USD | 97.636% |
| Santhera Pharmaceuticals Holding AG | -6.3 Million USD | 116.046% |
| Propanc Biopharma, Inc. | 927.18 Thousand USD | -9.107% |
| Marizyme, Inc. | 18.56 Million USD | 94.552% |
| Genus plc | 190.6 Million USD | 99.469% |
| Pharming Group N.V. | 109.8 Million USD | 99.079% |
| Therapeutic Solutions International, Inc. | 860.24 Thousand USD | -17.598% |
| CNBX Pharmaceuticals Inc. | 1.21 Million USD | 16.662% |
| Nymox Pharmaceutical Corporation | 680 Thousand USD | -48.769% |
| ContraFect Corporation | -6.02 Million USD | 116.788% |
| RegeneRx Biopharmaceuticals, Inc. | 1.15 Million USD | 12.446% |
| IMV Inc. | 7.67 Million USD | 86.812% |
| AXIM Biotechnologies, Inc. | 5.5 Million USD | 81.613% |
| ONE Bio Corp. | 9.04 Million USD | 88.809% |
| RVL Pharmaceuticals plc | 12.94 Million USD | 92.186% |
| Mesoblast Limited | 55.85 Million USD | 98.189% |
| MultiCell Technologies, Inc. | 90.04 USD | -1123429.542% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| Emmaus Life Sciences, Inc. | 30.55 Million USD | 96.689% |
| Genscript Biotech Corporation | -1.06 Billion USD | 100.095% |
| Neon Bloom, Inc. | 622.36 Thousand USD | -62.546% |
| Mosaic ImmunoEngineering Inc. | 1 Million USD | -0.388% |
| Nanobac Pharmaceuticals, Incorporated | 4.11 Million USD | 75.434% |
| Biomind Labs Inc. | 711.4 Thousand USD | -42.202% |
| Provectus Biopharmaceuticals, Inc. | 1.99 Million USD | 49.403% |
| Oncotelic Therapeutics, Inc. | 12.8 Million USD | 92.101% |
| Skye Bioscience, Inc. | -5.72 Million USD | 117.681% |
| GlobeStar Therapeutics Corporation | 359.71 Thousand USD | -181.234% |
| VioQuest Pharmaceuticals, Inc. | 2.23 Million USD | 54.754% |
| THC Farmaceuticals, Inc. | 139.8 Thousand USD | -623.603% |
| PsyBio Therapeutics Corp. | 134.63 Thousand USD | -651.362% |
| Arch Therapeutics, Inc. | 5.64 Million USD | 82.09% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| Acro Biomedical Co., Ltd. | 19.86 Thousand USD | -4991.992% |
| Accustem Sciences Inc. | -733.97 Thousand USD | 237.828% |
| EV Biologics, Inc. | 1.36 Million USD | 26.049% |
| Q BioMed Inc. | 4.06 Million USD | 75.083% |
| GB Sciences, Inc. | 1.74 Million USD | 42.104% |
| Alpha Cognition Inc. | -183.78 Thousand USD | 650.431% |
| CSL Limited | 10.52 Billion USD | 99.99% |
| Agentix Corp. | 37.63 Thousand USD | -2588.278% |
| American Oriental Bioengineering, Inc. | 60.54 Million USD | 98.329% |
| Enzolytics Inc. | 981.65 Thousand USD | -3.053% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Resverlogix Corp. | 6.45 Million USD | 84.318% |
| Nuo Therapeutics, Inc. | -673.08 Thousand USD | 250.296% |
| MetaStat, Inc. | - USD | -Infinity% |
| Curative Biotechnology, Inc. | 2.2 Million USD | 54.058% |
| argenx SE | -2.02 Billion USD | 100.05% |
| Northwest Biotherapeutics, Inc. | 43.43 Million USD | 97.671% |
| HST Global, Inc. | 96.79 Thousand USD | -945.144% |
| Enzon Pharmaceuticals, Inc. | -47.01 Million USD | 102.152% |
| Wesana Health Holdings Inc. | 206.21 Thousand USD | -390.564% |
| Halberd Corporation | 144.72 Thousand USD | -599.018% |
| Endonovo Therapeutics, Inc. | 7.07 Million USD | 85.693% |
| Inhibitor Therapeutics, Inc. | -8.83 Million USD | 111.444% |
| Zenith Capital Corp. | 10.06 Thousand USD | -9951.928% |
| RespireRx Pharmaceuticals Inc. | 2.7 Million USD | 62.652% |
| GeneThera, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 2.38 Million USD | 57.602% |
| AVAX Technologies, Inc. | -5.9 Million USD | 117.137% |
| WPD Pharmaceuticals Inc. | 164.5 Thousand USD | -514.937% |
| Cotinga Pharmaceuticals Inc. | -18.31 Thousand USD | 5622.579% |
| Ember Therapeutics, Inc. | 200.43 Thousand USD | -404.723% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Adynxx, Inc. | - USD | -Infinity% |
| NovAccess Global Inc. | 2.17 Million USD | 53.562% |
| Helix BioMedix, Inc. | -2.57 Million USD | 139.362% |
| Capstone Therapeutics Corp. | 20.27 Million USD | 95.011% |
| Kadimastem Ltd | -253.1 Thousand USD | 499.691% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| BioStem Technologies, Inc. | 4.47 Million USD | 77.379% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 201.25 Thousand USD | -402.661% |
| Burzynski Research Institute, Inc. | -1310.00 USD | 77323.359% |
| LadRx Corporation | -2.03 Million USD | 149.675% |
| Cell Source, Inc. | 9.23 Million USD | 89.042% |
| ProtoKinetix, Incorporated | -20.4 Thousand USD | 5057.007% |
| Regen BioPharma, Inc. | 635.16 Thousand USD | -59.269% |
| Regen BioPharma, Inc. | 635.16 Thousand USD | -59.269% |
| Affymax, Inc. | -5.59 Million USD | 118.074% |
| Mobile Lads Corp. | 484.23 Thousand USD | -108.913% |
| Itoco Inc. | 228.3 Thousand USD | -343.103% |
| Rasna Therapeutics, Inc. | 135.98 Thousand USD | -643.903% |
| Pathfinder Cell Therapy, Inc. | 4.95 Million USD | 79.592% |
| International Stem Cell Corporation | 2.59 Million USD | 60.941% |
| CytoDyn Inc. | 20.26 Million USD | 95.007% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | -647.00 USD | 156456.414% |
| NanoSphere Health Sciences Inc. | -9268.34 USD | 11014.856% |
| Qrons Inc. | 351.42 Thousand USD | -187.862% |
| Alseres Pharmaceuticals, Inc. | 7.7 Million USD | 86.872% |
| SYBLEU INC | 473.71 Thousand USD | -113.552% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | -249.62 Thousand USD | 505.266% |
| Rebus Holdings, Inc. | 305 Thousand USD | -231.681% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 4.45 Million USD | 77.303% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 62.41 Thousand USD | -1520.858% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 2.18 Million USD | 53.614% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 3.43 Million USD | 70.541% |
| Adhera Therapeutics, Inc. | 8.55 Million USD | 88.172% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 772.6 Thousand USD | -30.937% |
| Innovation Pharmaceuticals Inc. | -1.25 Million USD | 180.93% |
| Neutra Corp. | 52.18 Thousand USD | -1838.464% |
| Windtree Therapeutics, Inc. | -2.48 Million USD | 140.644% |
| PureTech Health plc | -167.19 Million USD | 100.605% |
| Coeptis Therapeutics, Inc. | -244.9 Thousand USD | 513.064% |
| IXICO plc | -4.44 Million USD | 122.761% |
| IntelGenx Technologies Corp. | 13.21 Million USD | 92.347% |
| Gelesis Holdings, Inc. | 54.85 Million USD | 98.156% |
| CSL Limited | 10.52 Billion USD | 99.99% |
| Cellectis S.A. | -43.81 Million USD | 102.309% |